ÂÜÀòÂÒÂ×

Nick Glover is an accomplished executive in the biotechnology and pharmaceutical industries, currently serving as CEO of MycRx since 2020, focusing on developing innovative cancer therapeutics. Glover has extensive experience in leadership roles, including strategic adviser positions at multiple companies such as Phoenix Molecular Designs and Pattern Pharma, and board memberships with organizations like PDX Pharmaceuticals and MEI Pharma. Glover previously held CEO positions at Sierra Oncology and YM BioSciences, overseeing significant acquisitions and advancements in cancer treatment. With a strong academic background, including a Ph.D. in Chemistry from Simon Fraser University, Glover contributes over 25 years of expertise in drug discovery, pharmaceutical development, and corporate strategy through consulting and advisory engagements.